Table 3.
Vaccine OR and RRR of laboratory confirmed-cases, hospitalisations and deaths per week and number of events for vaccinated (n= 40539) and unvaccinated (n= 39439) groups. Data are presented as n (%). Effectiveness is presented as %[CI95%]
| Laboratory-confirmed cases¶ |
Hospitalisations |
Deaths |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Days after vaccination | N° events vaccinated | N° events unvaccinated | OR* | Effectiveness | N° events vaccinated | N° events unvaccinated | OR | Effectiveness | N° events vaccinated | N° events unvaccinated | OR | Effectiveness |
|
(0-6) |
55 (0·136%) |
189 (0·479%) |
0·28 [0·21-0·38] |
71·7 [61·8-79·0] |
4 (0·010%) |
19 (0·048%) |
0·21 [0·07-0·60] |
79·5 [39·8-93·0] |
2 (0·005%) |
9 (0·023%) |
0·22 [0·05-1] |
87·3 [58·0-96·2] |
|
(7-13) |
56 (0·138%) |
215 (0·545%) |
0·25 [0·19-0·34] |
74·7 [66·0-81·1] |
8 (0·020%) |
37 (0·094%) |
0·21 [0·10-0·45] |
79·0 [54·8-90·2] |
3 (0·007%) |
13 (0·033%) |
0·23 [0·06-0·79] |
85·1 [74·3-91·3] |
|
(14-20) |
32 (0·079%) |
239 (0·606%) |
0·13 [0·09-0·19] |
87·0 [81·2-91·0] |
4 (0·010%) |
15 (0·038%) |
0·26 [0·09-0·78] |
74·1 [21·8-91·4] |
4 (0·010%) |
17 (0·043%) |
0·23 [0·08-0·68] |
89·4 [75·5-95·5] |
|
(21-27) |
58 (0·143%) |
297 (0·753%) |
0·19 [0·14-0·25] |
81·0 [74·8-85·7] |
2 (0·005%) |
33 (0·084%) |
0·06 [0·01-0·25] |
94·1 [75·4-98·6] |
3 (0·007%) |
25 (0·063%) |
0·12 [0·04-0·39] |
81·9 [66·4-90·2] |
|
(28-34) |
77 (0·190%) |
333 (0·844%) |
0·23 [0·18-0·29] |
77·5 [71·2-82·4] |
6 (0·015%) |
61 (0·155%) |
0·10 [0·04-0·22] |
90·4 [77·9-95·9] |
4 (0·010%) |
57 (0·145%) |
0·07 [0·02-0·19] |
87·5 [75·9-93·5] |
|
35 - end) |
113 (0·280%) |
429 (1,088%) |
0·26 [0·21-0·32] |
74·4 [68·5-79·2] |
16 (0·039%) |
131 (0·332%) |
0·12 [0·07-0·20] |
88·1 [80·0-92·9] |
24 (0·059%) |
165 (0·418%) |
0·14 [0·09-0·22] |
81·3 [60·2-91·2] |
¶
This includes asymptomatic infections by SARS-CoV2 and symptomatic infections (COVID-19).
⁎
Odds Ratio